

SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.


Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
"In the Trump administration, money beats MAHA every time."
It was already known that President Donald Trump pressured top health officials to allow flavored vapes to hit the market after being leaned on by Big Tobacco executives earlier this month.
But The New York Times has revealed that the decision came just over a week after a massive super political action committee (PAC) donation from one of the cigarette companies looking to have the regulations lifted.
Kenneth Vogel and Christina Jewett reported for the Times that on April 30, a subsidiary of the tobacco company Reynolds Americans—which owns Camel and Lucky Strike cigarettes—donated $5 million to the Trump-backed super PAC MAGA Inc., according to a financial report filed on Wednesday. It brought the total amount donated to the PAC up to $8 million.
The donation came just two days before tobacco industry executives held their sit-down with Trump at his golf club in Jupiter, Florida, where they told the president they were displeased with the FDA's ban on flavored vapes, which was enacted in light of evidence that they were driving an epidemic of youth vaping.
According to a youth survey by the Centers for Disease Control and Prevention (CDC), the vast majority of middle- and high school-aged e-cigarette users prefer fruit and candy-flavored vapes.
The Times reported earlier this month that immediately after receiving an earful from executives at Reynolds and Philip Morris owner Altria, Trump rang Secretary of Health and Human Services Robert F. Kennedy, Jr., and Centers for Medicare and Medicaid Services head Mehmet Oz to complain about the FDA's ban on e-cigarettes.
In the days that followed the meeting, Trump reportedly berated then-FDA Commissioner Marty Makary, who hesitated to reverse the policy due to the potential impact on children. Makary ultimately resigned less than a week later, along with RFK Jr.'s chief spokesperson, Rich Danker, citing disagreement about the e-cigarette policy change as the ultimate reason.
Within a week of the meeting with executives, the FDA announced it was dropping the ban on fruit-flavored vapes and authorizing the sale of mango and blueberry flavors by the Los Angeles-based company Glas Inc., which could pave the way for major cigarette makers to launch their own products on store shelves. It also allowed companies to add greater amounts of nicotine to pouches, which smokers often use in order to quit the habit.
Kush Desai, a spokesperson for the White House, told the Times that Reynolds' $5 million donation to the MAGA Inc. PAC had nothing to do with the administration's sudden shift in policy surrounding flavored vapes. He said "the only guiding factor behind the Trump administration’s health policymaking is gold standard science," as well as "recent evidence that has found [vapes] can help adults quit smoking.”
A spokesperson for MAGA Inc. said his organization “is pleased to accept legal contributions from those who agree with President Trump’s America First agenda and his goal to make America great again.”
The $5 million donation is far from the only contribution Big Tobacco has made to Trump. As Common Dreams reported earlier this month:
Trump, who ran in 2024 on a pledge to “save vaping” as part of an effort to appeal to young voters, has raked in huge sums of money from the tobacco industry. According to data from OpenSecrets, his inaugural committee took over $3 million from vaping special interests, including $1.25 million from the Vapor Technology Association, and $1 million apiece from Altria and Breeze Smoke.
Altria, which owns Marlboro maker Philip Morris, and Reynolds American, which owns Lucky Strike and Camel, have also offered donations to Trump’s $400 million White House ballroom project. Reynolds, the biggest producer of menthol cigarettes, also gave $10 million to the super PAC backing Trump in 2024.
The Times also reported on Wednesday that a Reynolds executive was invited to a dinner hosted by Trump at the White House in October for donors who gave $2.5 million or more.
The open, shameless grift.www.nytimes.com/2026/05/20/u...
[image or embed]
— Wajahat Ali (@wajali.bsky.social) May 21, 2026 at 1:21 AM
Critics described the $5 million donation as effectively a legal "bribe" to Trump and the latest example of the White House's "open, shameless grift."
It comes amid what seem to be endless reports of blatant self-dealing by Trump allies, most recently exemplified by the Trump-controlled Department of Justice's settlement of a lawsuit from Trump against the Internal Revenue Service, which handed the president $1.8 billion in taxpayer funds that he plans to disperse to his allies as part of a so-called “weaponization fund,” which critics have dubbed a “slush fund.”
It's also the latest example of Trump appearing to take actions in direct service of rich corporate donors—particularly in the fossil fuel, artificial intelligence, and cryptocurrency industries—or members of his family or personal inner circle.
Rep. Seth Magaziner (D-RI) also described the FDA's policy change on vaping as a betrayal by the administration's overseer, Kennedy. Though the HHS secretary has built his brand on pledges to "Make America Healthy Again" by decoupling corporate interests from health policy, he has been accused of bending to industry pressure on everything from food regulation to cancer-causing pesticides.
"In the Trump administration," Magaziner said, "money beats MAHA every time."
"The festering swamp of corruption and self-dealing surrounding the Trump White House just got even deeper."
US Health and Human Services Secretary Robert F. Kennedy Jr.'s son, Finn Kennedy, is reportedly seeking to raise $100 million for a new healthcare industry investment fund that will seek to capitalize on "policy initiatives in government"—including RFK Jr.'s so-called Make America Healthy Again agenda.
The Financial Times reported Friday that Finn Kennedy's fund, Victura Ventures, has already secured roughly $70 million in commitments. The fund is "targeting early-stage growth companies involved in healthcare AI, consumer health, and other health technologies," FT reported, citing an offering document.
"Kennedy’s foray into healthcare investing marks the latest example of the cozy relationship between the Trump administration and close associates who have sought to capitalize on it," the newspaper added. "Sons of President Donald Trump and Commerce Secretary Howard Lutnick have invested in cryptocurrency businesses as Trump has promoted alternative currencies. Donald Trump Jr. has joined the board of 1789 Capital, a fund founded by pro-Trump donors in 2023. At least four of 1789’s portfolio companies have won contracts from the Trump administration. 1789 has also invested in big government contractors, such as Anduril and Elon Musk’s SpaceX."
Additionally, as Common Dreams reported on Thursday, Eric Trump appeared on Fox Business to brag about a $24 million Pentagon contract secured by Foundation Future Industries, where the president's son serves as chief strategy adviser.
"These people are shameless," journalist Doug Henwood wrote in response to the reporting on Finn Kennedy's new fund.
The advocacy group Protect Our Care said the FT reporting and a Friday story in The New York Times—which detailed how a top Kennedy aide "was advising on changes to the American health system while running a rapidly growing wellness company poised to benefit from Trump administration health policies"—show that "the festering swamp of corruption and self-dealing surrounding the Trump White House just got even deeper."
According to the Times, Kennedy aide Calley Means "held between $25 million and $50 million in stock in the company, Truemed, through November, as he continued to serve as its president."
"For months, Mr. Means has ignored questions from Democrats in Congress about his finances, including the extent of his stake in Truemed, and how they related to federal policy," the Times added.
Kayla Hancock, the director of Protect Our Care’s Public Health Project, said in a statement Friday that "it’s perhaps easy for RFK Jr. to look at Donald Trump and Commerce Secretary Lutnick blatantly abuse the power of the White House to enrich themselves, family members, and big donors, and say, ‘Why not me?’"
"Kennedy claims he’s following ethics rules, but why did he keep the barn door open for his son and close associates to profit off his policy decisions?" asked Hancock. "It follows a corrupt pattern of Trump administration officials exploiting loopholes to steer money into their family and friends’ pockets at the same time they rip away healthcare from millions of Americans and push policies that hike costs on everything from insurance premiums, gas, to groceries.”
"You can't just redefine how you calculate percentages," said one mathematician in response to Kennedy's claims.
US Health and Human Services Secretary Robert F. Kennedy Jr. on Wednesday tried to defend President Donald Trump's mathematically absurd claims about prescription drug prices by saying the president has his own unique method of calculating percentages.
During a Senate Finance Committee hearing, Sen. Elizabeth Warren (D-Mass.) grilled Kennedy about the president's repeated false claims that he has slashed the prices of prescription drugs by as much as 600%, which would mean that pharmaceutical companies are paying consumers to take their medications.
"President Trump has his own way of calculating," Kennedy replied. "There's two ways of calculating percentages. If you have a $600 drug, and you reduce it to $10, that's a 600% reduction."
RFK Jr: "President Trump has a different way of calculating percentages. If you have a $600 drug and you reduce it to $10, that's a 600% reduction." pic.twitter.com/MjDNADqc8p
— Aaron Rupar (@atrupar) April 22, 2026
In fact, such a drop in price would represent a 98.3% reduction, less than one-sixth the size of the president's claims. A 600% reduction in the price of a $600 drug would mean that drug manufacturer paid consumers $3,000 every time they picked up their prescription.
Kit Yates, a mathematician at the University of Bath, marveled at Kennedy's attempts to create an alternate version of arithmetic.
"We've known for a while that the USA's current regime have been out for science, but I never thought they would try to mess with math!" Yates wrote in a social media post. "You can't just redefine how you calculate percentages."
In addition to exposing Kennedy's apparent ignorance of elementary mathematics, Warren shined a light on how the TrumpRx website misleads consumers into thinking they're being offered bargains on prescription drugs that are available elsewhere in generic varieties.
In once instance, Warren noted that TrumpRx is selling a brand-name heartburn medication for $200, whereas a generic version of the same drug is available at Costco for $16. Warren also highlighted a heart arrhythmia drug for sale on TrumpRx for $336, even though a generic version of the drug is available at Costco for $12.
Warren added that, in exchange for making select brand-name drugs available on the TrumpRx website, pharmaceutical companies have gotten exemptions from the president's 100% tariffs on imported patented medicines.
"Think about that: Big Pharma makes billions of dollars in tariff relief by listing their drugs on TrumpRx, and then they don't even lower the costs on many of these drugs," she said. "That is a great deal for Big Pharma."
Warren's analysis of TrumpRx's pricing scheme echoes a March report from the Center for American Progress (CAP), which found that the president's prescription drug website offered genuinely lower prices on “exactly one” of the 54 medications listed.
CAP also found that nearly one-third of the drugs available on the TrumpRx website have generic alternatives that were cheaper than what was being offered, and that the website made no mention of this.
Reuters reported in December that at least 350 branded medications are set for price hikes in 2026, including “vaccines against Covid, RSV, and shingles,” as well as the “blockbuster cancer treatment Ibrance.”
Later in the Senate Finance Committee hearing, Sen. Bernie Sanders (I-Vt.) ridiculed Kennedy for claiming that, under Trump's leadership, "the American people are now paying the lowest costs in the world rather than the highest for prescription drugs."
"That is an absurd statement," Sanders said. "Nobody in the world believes that."